Jing-Dong Zhou (Jingdong Zhou)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 14

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Disease Activity

Long Noncoding Rna

Top Venues

Journal of cellular physiology

Cancer medicine

Clinical epigenetics

This page only lists publications with an associated author ORCID identifier.

Publications

Yangjing Zhao, Weili Cai, Ye Hua, Xiaochen Yang, Jing-Dong Zhou
The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid Malignancies. Cancers 14 (18) (2022)
Yangjing Zhao, Hui Wang, Jing-Dong Zhou, Qixiang Shao
Glutathione Peroxidase GPX1 and Its Dichotomous Roles in Cancer. Cancers 14 (10) (2022)
Fang-Yu Nan, Yu Gu, Zi-Jun Xu, Guo-Kang Sun, Jing-Dong Zhou, Ting-Juan Zhang, Ji-Chun Ma, Jia-Yan Leng, Jiang Lin, Jun Qian
Abnormal expression and methylation of PRR34-AS1 are associated with adverse outcomes in acute myeloid leukemia. Cancer medicine 10 (15) (2021)
Ting-Juan Zhang, Zi-Jun Xu, Yu Gu, Ji-Chun Ma, Xiang-Mei Wen, Wei Zhang, Zhao-Qun Deng, Jun Qian, Jiang Lin, Jing-Dong Zhou
Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia. Clinical epigenetics 13 (1) (2021)
Ming-Qiang Chu, Liu-Chao Zhang, Qian Yuan, Ting-Juan Zhang, Jing-Dong Zhou
Distinct associations of NEDD4L expression with genetic abnormalities and prognosis in acute myeloid leukemia. Cancer cell international 21 (1) (2021)
Ting-Juan Zhang, Zi-Jun Xu, Yu Gu, Xiang-Mei Wen, Ji-Chun Ma, Wei Zhang, Zhao-Qun Deng, Jia-Yan Leng, Jun Qian, Jiang Lin, Jing-Dong Zhou
Identification and validation of prognosis-related DLX5 methylation as an epigenetic driver in myeloid neoplasms. Clinical and translational medicine 10 (2) (2020)
Guo-Kang Sun, Li-Juan Tang, Jing-Dong Zhou, Zi-Jun Xu, Lan Yang, Qian Yuan, Ji-Chun Ma, Xing-Hui Liu, Jiang Lin, Jun Qian, Dong-Ming Yao
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia. Cancer medicine 8 (14) (2019)
Ming-Qiang Chu, Ting-Juan Zhang, Zi-Jun Xu, Yu Gu, Ji-Chun Ma, Wei Zhang, Xiang-Mei Wen, Jiang Lin, Jun Qian, Jing-Dong Zhou
EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia. Journal of cellular and molecular medicine 24 (2) (2019)
Ting-Juan Zhang, Jing-Dong Zhou, Dong-Qin Yang, Yu-Xin Wang, Xiang-Mei Wen, Hong Guo, Lei Yang, Xin-Yue Lian, Jiang Lin, Jun Qian
TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia. Journal of cellular physiology 233 (8) (2018)
Pin-Fang He, Zi-Jun Xu, Jing-Dong Zhou, Xi-Xi Li, Wei Zhang, De-Hong Wu, Zhi-Hui Zhang, Xin-Yue Lian, Xin-Yu Yao, Zhao-Qun Deng, Jiang Lin, Jun Qian
Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia. Journal of cellular physiology 233 (9) (2018)
Zhi-Hui Zhang, Wei Zhang, Jing-Dong Zhou, Ting-Juan Zhang, Ji-Chun Ma, Zi-Jun Xu, Xin-Yue Lian, De-Hong Wu, Xiang-Mei Wen, Zhao-Qun Deng, Jiang Lin, Jun Qian
Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia. Molecular carcinogenesis 57 (6) (2018)
Jing-Dong Zhou, Ting-Juan Zhang, Xi-Xi Li, Ji-Chun Ma, Hong Guo, Xiang-Mei Wen, Dong-Ming Yao, Wei Zhang, Jiang Lin, Jun Qian
Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia. Journal of cellular physiology 233 (6) (2018)
Ting-Juan Zhang, De-Hong Wu, Jing-Dong Zhou, Xi-Xi Li, Wei Zhang, Hong Guo, Ji-Chun Ma, Zhao-Qun Deng, Jiang Lin, Jun Qian
Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia. Journal of cellular physiology 233 (4) (2017)
Jing-Dong Zhou, Jiang Lin, Ting-Juan Zhang, Ji-Chun Ma, Xi-Xi Li, Xiang-Mei Wen, Hong Guo, Zi-Jun Xu, Zhao-Qun Deng, Wei Zhang, Jun Qian
Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia. Journal of cellular physiology 233 (3) (2017)